Stats

P1 RawdelayedSIP16:16 TYRA20.925 +12.1383%open but-21.7172%prior; IRD5.585 +28.6866%prior but-21.0042%high7.07; INBX122.85 +7.4427%prior but-4.4266%high. Both directions recorded, no posthocwinningentry. P2 TYRA/IRD/SPY167of167minutes; INBX129of167,38missingnotfilled. P3 SPY761.46 vs13:59 764.10=-.3455%,descriptive notcausal release response. P4 IEX16:32 IRD17.81bps spread improvesexecutiononly; TYRA/INBX affordablecross23.87/33.26USD exceed8.5099risk. Onevenuequotes notNBBO; delayedbarsnotfills; stops15mincannotboundjumps. Conclusion no signal override to failednetedge. Source https://runway.adityaperswal.workers.dev/data/stock-bars and /data/stock-snapshots ; observations18551–57.

P1 Original1642 re-read, not rerun: frozen2016–20train/2021–25holdout, IBS<=.2 nextopen1ADRstop/1.5ADRtargetorclose,fee1bp+slip5bpsside,vectorbt cashcurvereconciled. Holdout252,-21.631824%,DD25.206217%,p45.634921%,cashW.490801991%,L.585547862%,mean-.094356461%; stress-52.657075%. P2 2026extensionN28+2.31%base/-3.26%stress cannot replace holdout. P3 query_trades threeoperatorliquidations p1/3,W7.93994%,L5.26143%,mean-.860974%; censored4–6weektheses, no slippagebenchmarks. Both clippedquarterKelly=max(0,.25*(p-(1-p)*L/W))=0. Conclusion allocation0 valid under gate; soundness conditional on cost/data assumptions, not proof allquantfails. Clinicalresponses and intradaymoves not independentstockwinprobability. Need untouched matchedclinicalpanel/costedactualexits to change decision. Obs18550/18558; source https://runway.adityaperswal.workers.dev/data/stock-bars and query_trades fund=quant.

Premises source cashclassifications and guide periods in18559–61. Firstorder ASOrefundfinanciers receive72.224m ahead of cash retainedforowners; KFYacquisition expandsfees butaddsinterest/shares; CHWYguide modestlyhigherwithacquiredcontributions. Secondorder inference customerprice reinvestment/bonuspayments/integration and debtservice can absorb grossprofit; creditors,employees,sellers andcustomers may benefit before publicequity. Thirdorder conditional only incrementalorganiccollections andreturnsoninvestedcapital abovefundingcost compoundownerscash; otherwise largerrevenues supportlarger obligations. Strongestcounterargument repurchases,marginimprovement and crossselling can beatcosts, so do notcallaccountingbridges bearish stockforecasts. No namedbeneficiary trade orseparateFUND absentvalidatedpayoff. Sources https://www.sec.gov/Archives/edgar/data/1817358/000181735826000146/exhibit991pressreleaseq220.htm ; https://d1io3yog0oux5.cloudfront.net/_77708ab48ef2edbffdcc42caba8d0da4/kornferry/db/1130/10800/presentation/FY27-Q1-Earnings-Call-Presentation-Final.pdf ; https://s23.q4cdn.com/610444331/files/content_files/CHWY-Q2-2026-Earnings-Presentation.pdf .

Reuse1734/1720/1682 NumPyseed2026090908 bootstrap50000paths of10selectedtimeonlyeventreturns, with1685capitalKellyunitcorrection. Hypothetical25%capital meanterminal51.17792 from49.14,5/50/95%=47.38995/50.79397/56.33595,lossprob25.418%. These10events are notremainingmonth opportunities; requiredcoststressedstop/targettestnegative. NewLOVEpaperunfinished at16:14data cutoff so no empiricaldistribution update. Counterexampleconditionalpositive mean would favor risk if independentlycredible, but simulationsaddnopopulationdataandnotvalidatevenueexits. Adoptedallocation0 gives49.14terminalbefore externalcosts; do not advertise hypotheticaltrade odds. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; reused analyses1734/1682/1685.

Read1733/1736 and original-study summaries38/1677/1678/1688; no identicalrerun. CHWY chronologicalN6 p.5 avgwin4.523391% avgloss4.828695%,return-1.719988%,DD14.258614%; PythonfractionKellycapital=(p/L-(1-p)/W)/4=-.1747224067 clipped0. Prospectivepre-eventCHWY N1 -2.687668%keptseparate. LOVErequiredexitsN10basep.3 W7.292817% L2.929065% return-.368512%,DD12.286896%;stressp.2 W10.702374% L2.753813%,return-2.341352%,mean-.062576%,meanCI[-3.319283,4.058455]%. Selectedtimeonlypositive result not executableedge. Ownledgerrecomputedfrom3fills0wins,avg loss16.3806011337%,avgwinnerundefined;2operatorliquidations censorintent. Samplingselected/small; cannotproveuniversalnegativeedge. Credible independentnetmean withactual15minexits would moveallocation above0 subjectcaps, today'snewsdoesnot. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; runway:query_trades?fund=catalyst ; observations18565 and original analyses38/1677.

1.Explicitdelayedend16:14UTC suppliesCHWY09:50minuteC21.595 vsIEX21.59; exactNBBO stillunknown. CHWY16:14C20.91 vsprior23.27=-10.1418%,vsopen21.85=-4.3021%; SPY-.5633%prior. Descriptive relativeweakness not causation or validateddrift.2.FrozenLOVEpaperentry15.87,ADR.655065 stop15.214935,target16.8525975,timeexit19:45UTC;11completed15mincloses through16:00start no trigger, latest15.76,whole intradayrange15.455–16.23.3.Sparseminute14 extraction missed4 checkpoints; fetchednative15minbars instead, no forwardfilled inventedtrades. PriorSMA/ADR unchanged completedSep8; currentLOVEbelow16.47025SMA and CHWYbelow23.378SMA does not overridefailededge. Strongcounterexample rebound laterpossible; no prematureoutcome or lateentry. Sources https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE&timeframe=15Min&start=2026-09-09T13:30:00Z&end=2026-09-09T16:14:00Z&feed=sip&adjustment=all ; observations18562–64.

Premises:1. Original CHWY Sep9p9 confirms FY13.46–13.57bn/6.7–6.8% margin vsJune13.40–13.55bn/6.6–6.8%; midpoint+40m/.296846% and+5bp. ExacquisitionFYgrowth5.5–6.3%,Q3 5.3–6.2%; raise is not proof organic acceleration.2.ASO H1FCF237.558m includes refunds while72.224m claimremittance sits in financing; analytical subtraction165.334m is retained cash before otherfinancing, not normalizedFCF. Unknowngrossreceipt prevents recurringcash estimate.3.KFY preAMSJul31cash/securities1051.1m less361.4m reserves=689.7m investable,down39.2m; rawcashdecline cannot be equated to operatingburn. Q2 includesAMSSept/Oct,interest13.4m and54m dilutedshares. Strongest counterargument improving acquired earnings and retainedcash may deliver future shareholder returns; absent fullOCF/call/ROIC/valuation cannot price them. Valid cash identities, sound only for source periods; no independent stock edge. Observations18559–61. Sources https://www.sec.gov/Archives/edgar/data/1817358/000181735826000146/exhibit991pressreleaseq220.htm ; https://d1io3yog0oux5.cloudfront.net/_77708ab48ef2edbffdcc42caba8d0da4/kornferry/db/1130/10800/presentation/FY27-Q1-Earnings-Call-Presentation-Final.pdf ; https://s23.q4cdn.com/610444331/files/content_files/CHWY-Q2-2026-Earnings-Presentation.pdf ; June https://s23.q4cdn.com/610444331/files/doc_financials/2026/q1/CHWY-Q1-2026-Earnings-Presentation.pdf .

Start state crypto235.86cash/system850.99equity,no positions/queuedorders; goalrepeatablenetprofit; bindingconstraintvalidatedpositive entry expectancy. Numbered premises:1 Frozen daily/hourly/15min tests remain rejected, technical1748 and observation18546 preserve quarterKelly0; arithmetic recheck is not new backtest.2 Fundamental1747 and consequences1749 identify actual macro releases/newETFdatedstocks but no quantified entry-conditioned spotprice edge; source gaps remain explicit.3 Fresh quotes18539 have .524/.524/.6061% majors recovery hurdles with assumedfees and limiteddisplayeddepth, which constrain but cannot create edge.4 OwnonlyN1operatorliquidation cannot estimate setup distribution. Conclusion No proposals. Validity sound: requiredpositiveedgeabsent implieszeroauthorizedsize; soundness constrained by historicalcoverage,serialdependence,costassumptions,publicationlag andunknownflowdestinations. Counterexample rally/newbuying is possible; this is abstention,notbearishforecast. Prior cash conclusion survives evidence; independent positive cost-stressed prospective samples and matching15minexecution could change it, monthlyshortfall cannot. Existing simulation1652 remains sensitivity only; do not generate redundantMonteCarlo/newtests to repackage failedsignal. Macro45 andflow138resolved; successor143review19:40, PPI122/Arc104retained. Jobs139/140cancelledexpired141done; locallytested143/144/145renewalsthrough19:41requested butfirstsavedoutputunverified; daily14/25retained. All three lessonkinds recorded. Run elapsed~4.5min vs35minallowance/45hard; no orders placed. Sources https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://runway.adityaperswal.workers.dev/data/crypto-snapshots ; https://www.census.gov/services/current/index.html ; https://www.bls.gov/news.release/ecec.nr0.htm ; https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf/latest-holdings.csv ; https://blockstream.info/liquid/api/blocks .

Premises:1 Verified Q2nominal services growth+3.0% and Junecompensation levels do not identify an unexpected real-demand or policy shock. 2 NewETFend-date BTCstockdelta135.8554 is not known new spot buying at review time. 3 Liquid operator preparation does not prove authorized payouts. First order: stronger activity can support revenues while sustained costs constrain monetary easing; custody restoration would make claimant assets available. Second order: investors may adjust rate/risk expectations, and claimants may hold,sell orhedge rather than buy; intermediaries benefit from transaction activity. Third order: price effects depend on opposing flows and can be absorbed before fees/spreads are earned. Conclusion no directional or quantitative expected-return inference; these are scenarios, not forecasts. Strongest bullish case improving growth plus recovered confidence drives inflows; strongest adverse case higher discount rates plus claimant sales dominates. Neither has independently measured probability/payoff. Binding constraint remains validated entry edge. https://www.census.gov/services/current/index.html ; https://www.bls.gov/news.release/ecec.nr0.htm ; https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf/latest-holdings.csv ; https://x.com/Blockstream ; https://blockstream.info/liquid/api/blocks .

Premises: 1 Reuse costed frozen daily/hourly/15minute studies1639–1641/1698/1726; this is a trading review, no new backtest/refit/independent sample. BTC35/82win,avgwin2.642605%,loss3.080586%;ETH27/61,4.139850%/4.236197%;SOL33/70,4.496455%/4.301185%. Cash expectancy remains -.637761/-.528766/-.153726% pertrade, approved quarterKelly0. Prior 15minute holdouts return-43.5409/-32.9637/-18.7330%; pullbackN1–5 also rejected. 2 Completed daily bar sameSep8 as1728, RSI2 16.527/40.992/36.248 above frozen10; intradayquote does not replace daily signal. 3 16:32quotesBTC78739.049/78756.4 ETH2494.7/2495.25 SOL103.193/103.3; assumed25bp creditedasset fees eachside plus spread require .524/.524/.6061% recovery. Topask78.19/82.79/295.07USD; firsttwo below212.7475cap, onequote notdepth. 9/10fresh USDG stale. 4 OwnhistoryN1forcedliquidation cannot supply edge/execution distribution; no holdings/queuedorders to exit or adjust. Conclusion allocation0; limit savings cannot cure unvalidated entries without executable fill evidence. Sampling/serialdependence/costassumptions remain limitations; a rally is not evidence of positive entry-conditioned payoff. Sources https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://runway.adityaperswal.workers.dev/data/crypto-snapshots ; https://docs.alpaca.markets/us/docs/crypto-fees . Observations18539/18546.

Premises: 1 Sep9 actual BLSJuneECEC/private46.89USD/hour is a level affected by composition, not a measured benign wage-inflation surprise; CensusQ2selectedservices nominal6418.7bn,+3.0%QoQ/+7.6%YoY is firm nominal activity, not real growth. 2 Fresh issuer CSVs nowSep8: IBIT785771.1727BTC versusSep4 785635.3173,+135.8554BTC over4calendar days; ETHA3527867.3679ETH unchanged despite earlier share issuance. These are end-date stocks, not a verified trade tape; settlement/baskets/definitions need reconciliation before demand claims. 3 CircleSep7 issuance8.8-redemption7.86=.94bn/week,134.286m/day arithmetic average, unchanged publication; USDCwebdateunknown and Llama different definition cannot imply incremental buying. 4 Liquid59.725h stale tip/secondaryerror and unchanged operator preparation do not verify recovery or authorized payout; GME latest10QJune11 leaves quantities/counterparty unknown. Conclusion update context, retain zero trade. Source proximity: agencies conduct surveys, issuers own records but have promotional incentives, explorer partial and operator interested. Strongest counterargument: new buying/recovery can occur before disclosure; that makes timing unknown rather than bearish. Validity: no identified price edge means entry gate unmet. Soundness limited by publication lag and missing flow destinations. Sources https://www.bls.gov/news.release/ecec.nr0.htm ; https://www.bls.gov/news.release/ecec.tn.htm ; https://www.census.gov/services/current/index.html ; https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf/latest-holdings.csv ; https://www.ishares.com/us/products/337614/ishares-ethereum-trust-etf/latest-holdings.csv ; https://www.circle.com/transparency ; https://data.sec.gov/submissions/CIK0001326380.json ; https://blockstream.info/liquid/api/blocks ; https://x.com/Blockstream . Observations18529,18540,18544,18545.

Numbered premises:1. Supplied account850.99cash/Supply278.67deployable; query_trades supply shows only2closedoperatorliquidations, no open/pending/closing lots https://runway.adityaperswal.workers.dev .2. New1743fundamental/1745consequences: Census Q2transport nominal revenue401.8bn+5.1%q/q https://www.census.gov/services/qss/qss-current.pdf and BLSJune49.86/hour https://www.bls.gov/news.release/ecec.t04.htm do not establish issuer margins; monitored originals have no verified new acceptedcash within bounded review.3. Statistical1744 preserves frozenFRO41meanCI[-.874362,1.958541]% and rawquarterKelly.024266693704,approved0 https://runway.adityaperswal.workers.dev/data/stock-bars .MATX1144 -1.1617%N13,ASPI-47.66%N24,SEI-48.92%N6,OESX-31.81%N4 remain rejected per saved1729 and monitors.4. No admissible stockedge -> no quote/lot/exit proposal constructed, no new backtest or refit. Conclusion no PROPOSE/EXIT/ADJUST/FUND. Valid under numericaledge requirement; counterexample truepositiveFROedge possible but independent prospective validation needed. Constraints cashonly,position212.7475,risk8.5099,fund278.67; approved0. Monitors78/139 resolved, successor142accepted19:40; preserve49EIA and11/133. Fiveexistingjobs active;116next17:00:45,11runs. Lessons540–542 recorded. Start16:30:42, closingphase16:33, ~4minutes total within35allowance/hard45; no overruns, finish reserve intact. Gaps ASPIQ&A,matchedhistoricalcost/marginbridge,CENTCOM/ACP/Bombardiercollectorfailures. No claim of complete news coverage.

Premises1 CensustransportQ2nominalSA+5.1%q/q https://www.census.gov/services/qss/qss-current.pdf ;2 BLSJune49.86/hourtransportcomp https://www.bls.gov/news.release/ecec.t04.htm ;3 monitoredissuer accepted margins incomplete per current fundamental. First order: higher cargo prices or volumes lift nominal revenue; cannot separate components here. Second order: scarce vessel/equipment owners benefit only if receipts exceed labor, fuel, insurance, supplierrights and financing, while shippers/buyers may absorb costs. Third order: customer substitution, lower volume and capacity additions can erode rents before shareholders receive cash. All three are mechanisms, not measured elasticity. Start278.67cash; goal repeatable netreturns; binding constraint independent executable payoff edge and issuer cash attribution. Counterargument sustained rents could produce large profits; change thesis with verified profitable accepted fixtures/shipments, then validate net stockreturns rather than map macro growth directly to equity.

1. Saved1725/backtest456 provides41 holdout trades,17wins,meanwin5.46270406%,meanloss2.96357664%,costedreturn20.24256512%,drawdown24.4194659% https://runway.adityaperswal.workers.dev/data/stock-bars .2. Python recomputes expectancy.530247064878%,rawquarterKelly2.42666937%; savedmeanCI[-.874362,1.958541]% crosseszero. Same historical sample; not41newtrades.3. query_trades fund=supply two closed operator-liquidation winners only https://runway.adityaperswal.workers.dev ; no empirical average loss or planned-exit success estimate.4. Census roundedtransport figures imply19.497431bnq/q and44.008370bny/y gains; BLStransport/allprivatecomp premium6.333973% is cross-sectional, notinflation https://www.census.gov/services/qss/qss-current.pdf https://www.bls.gov/news.release/ecec.t04.htm .Conclusion allocation0. Truepositiveedge possible, but new macro print adds no independent return sample. Prior technical1702/indicators1631/simulation1630 retained as historical, not current recalculation. No fresh regression,MonteCarlo or backtest warranted for unchanged rejected rule on tradingrun.

Premises:1. Sep9 Census Q2 transport nominal SA revenue401.8bn,+5.1%q/q,+12.3%y/y https://www.census.gov/services/qss/qss-current.pdf ; selectedtotal6418.7bn,+3.0%q/q revised3.1 https://www.census.gov/services/current/index.html .2. June BLS transport compensation49.86/hour,wages32.95,benefits16.90 https://www.bls.gov/news.release/ecec.t04.htm .Different survey populations/units; ECEClevel is not fixed-mix inflation and no matched laborhours, fuel, insurance, cargo or issuer margins are supplied.3. FRO latest archiveAug28 https://www.frontlineplc.cy/category/press-releases/ ; ASPI prospective next12months https://ir.aspisotopes.com/news-events/press-releases/detail/119/asp-isotopes-hosts-inaugural-capital-markets-day-and ; SEI core+acquisitions https://ir.solaris-energy.com/news/2026/09-08-2026-114509510 ; OESX repeat order no exactcash/margin https://investor.oriones.com/news-releases/news-release-details/orion-announces-additional-multimillion-dollar-data-center .Conclusion: nominal transport demand evidence improves context; delivered issuer netcash and independent stockedge remain binding. Counterexample genuine volume plus pricing could already lift margins, but neither aggregate demonstrates that. Do not label costs benign or adverse without matched historical evidence. Original agencies direct; issuer sales releases biased toward financing/commercial optimism. Coverage gaps: ASPIQ&A,CENTCOM,ACP,Bombardiercollector. Valid inference no automaticentry; soundness bounded by incomplete acceptedcash evidence.

StartQuantcash187.22/account850.99; goalrepeatablepositivecashreturns; bindingconstraintindependentnetedge. P1 Re-readfrozenbacktest1642:252EEMholdouttrades-21.6318%,stress-52.6571%,p45.6349%,cashW.490802%/L.585548%,quarterKelly0; all8main/all72stressfail per1690. No newstrategyfit/backtestclaimed. P2 OwnN3operatorliquidationsquarterKelly0,nonpredictiveresamplingreproduces1706. P3 FirstopenTYRA-30.19%,IRD+22.12%;13:52IRD+57.03%and29bpsspreadimprovesexecutionbutnotstockprobability. P4 CurrentTYRA31pagedeckrecovered:legacyitem21wrongyear,HR/DFSprojectionsmodeled,sponsorsurveysnotcash; IRDnonprespecifiedloci,INBXunchanged. ConclusionnoPROPOSE/EXIT/ADJUST/FUND,notional0; mandatorygatevalid,soundnessconditionalonproviderandmodel,notclaimallquantfails. Strongcounterargumentpositiveclinicalnews/narrowspreadcouldsupportdrift; requiresuntouchedcostedclinicalpanel/exits,notoneeventorrescuevariant. Analyses1737–1741,obs18501/03/05/18/19/25–28,lessons537–539. Monitor134resolved,next16:30clinicalsuccessorcreated;60/42/127retained. Truncated137cancelled,tested142scheduled30m7runs/hard16:45;13:58lastRun null meansremoteexecutionUNVERIFIED,localall3/footerpassed. Preserve15/84/85. GapsQ&A,liveSIP403,independentstockholdout/15minfills/unconditionalIRDfunding. Fullslidesgapresolved. Finalrecordphase13:57(~7min);completedunder33minplan/45hard. Sources https://ir.tyra.bio/static-files/e2ddb459-375e-49f8-a9ae-a5303c6d8e3a ; https://ir.opusgtx.com/presentations ; https://runway.adityaperswal.workers.dev/data/stock-bars .

1 TYRAoraltreatmentmayreduceproceduralburden; thencontrolledadjuvanttrialmustestablishdurablerecurrencebenefit; thenapproval,payerpricing,manufacturingandfundingmustconvertsalesintoequitycash. Survey38patientsand51urologists supportsinterestonly; fullpenetration>$5bnnotachievedcash. Sponsors/patientsbenefitfromdevelopment; financerscanbenefitwhileexistingholdersarediluted. 2 IRDfunctionalchangesmayadvancepivotaldesign; thenprespecifiedlociandrandomizedcomparisonmustreplicate; thenmanufacturing/funding/payersdeterminecapture. Nonprespecifiedcohortlociareexplicitcounterexampletoclaimcurrenttrialalreadysatisfiesfuturepivotalendpoint. 3 Strongpriceactionmayattractmomentumflows; thenliquiditycanimprovespread; thenlateentrantsmayfacecrowding/reversal. IRD29bpsspreadsupportssecondlinkonly,notpositivefutureexpectancy. Deductionvalid,mechanismsconditional; independentstockpayoffmissing. Source https://ir.tyra.bio/static-files/e2ddb459-375e-49f8-a9ae-a5303c6d8e3a ; https://ir.opusgtx.com/presentations . NoDCF/approvalprobabilityfabricated.

1 Re-run1706NumPyseed9091230 with actualthreeclosedreturnfractions[-.0539236448052,.0793994130743,-.0513049904703],20000paths20IIDdraws,compoundhypothetical187.22USD. P&L2.5/50/97.5pct[-93.669315,-30.013809,79.173517];loss81.26%. Reproducesoldresult,notnewtest. 2 IID/stationarity/executionunsupportedN3operatorliquidations. Resampling cannotgenerate missing independentinformation; donotinterpret81.26%asclinicaltradelossprobability. 3 ObservedquarterKelly0proposedUSD0; noassumed stop/targetorMonteCarloexitoddswithoutqualifiedrule. Hardconstraintsfund187.22,accountcap212.7475,risk8.5099 furtherlimit anyfuturepositiveedge. Source query_trades fund=quant IDs9/7/1; observations18528; prior1706. Validillustrationconditionalonexplicitunsupportedassumptions; cannotjustifyrisk.

1 Originalbacktest1642re-read,reusedNOT rerun: frozen2016–20train/2021–25holdout; IBS<=.2nextopen,1ADRstop/1.5ADRtargetorclose;fee1bp+slip5bpsside. EEM252holdoutreturn-21.6318%,DD25.2062%,p45.6349%,cashavgwin.490802%,loss.585548%,quarterKelly0;16bpssidestress-52.6571%. All8main/all72stresscellsnegative per1690. 2 Recomputequery_tradesIDs9/7/1:N3p1/3,avgwin7.93994%,loss5.26143%,mean-.860974%; quarterKellymax(0,.25*(p-(1-p)*L/W))=0. Operatorliquidationscensor4–6weektheses; noidentifiedslippageorstop/targethitrates. 3 ClinicalN14/N5andthreestocksselectedforeventsarenotstockwinprobability. Neitherpositive2026extension(base2.31%,stress-3.26%N28)norIRDtoday canreplacefailedholdout. Newuntouchedindependentclinicalpricepanelwithexactentries/costs/exitscouldmoveallocation; onepricecannot. Sources query_trades fund=quant ; https://runway.adityaperswal.workers.dev/data/stock-bars . Obs18528.

1 FrozenSep8SIPcloses26.73/4.34/114.34. Direct13:52delayedSIPfirst13:30minuteopensTYRA18.66(-30.1908%),IRD5.30(+22.1198%),INBX117.38(+2.6587%). Last13:36TYRA19.17/IRD6.13;INBX13:35 121.76. 7/7/6bars no pagination; boundary/missingnotfilled. 2 IEX13:52trades19.57/6.815/125.425 imply-26.7864/+57.0276/+9.6948%vspriorSIP; distinctfeeds/timesnotfills. IRDspread29.37bps from6.80/6.82 materiallyimprovesprior629bps;27shares184.14crosscost.54 versusTYRA9sharescross11.88 andINBX1share19.94, bothabove8.5099risk. These quotedcrossesillustrative notNBBO/fills. LiveSIP403. 3 Reboundandcontinuationretained equally; neitherselectsnewrule. Nominalstopcannotboundgap/15minlatency. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; https://runway.adityaperswal.workers.dev/data/stock-snapshots . Obs18501/03/05. Bindinggateindependentcostedclinicalstockedgeabsent; size0.

1 Currentir.tyra.bioevent yielded31pageSep9dataPDF; legacyitem21wasJune2023,correct18519/1709. p7primary3moCR;60mg8/14 differs8/8singlemarkerORR. p18PK172pooledsubjectsnottrialefficacyN172. p20DFS24m55/72/81% andHR.6/.3/.2 areexplicitillustrative assumptions,notobservedrandomizedhazardratios. 2 Augsponsorsurveys38patients/51urologists suggestconvenienceappeal,notrepresentativeuptake/paidprescriptions. >$5bnfullpenetrationmarket doesnotestimaterevenueorDCF; timelines2027/FDAfeedbackpending. 3 IRD36slidesp20/22/26reconfirmnonprespecifiedloci;threepatientgainsnotpivotalproof. INBXfullPDFshashesunchanged. Bullcounterexample:oralconvenienceandstrongfuturecontrolleddata couldcreaterealvalue; currentdata cannotquantifyapprovaloddsorremainingstockreturn. Sourceclosestissuerbutinterested; release/deck/surveynotindependentsources. Sources https://ir.tyra.bio/static-files/e2ddb459-375e-49f8-a9ae-a5303c6d8e3a ; https://ir.opusgtx.com/presentations ; https://inhibrx.com/hexagon-slides/ . Obs18518/25–27. Verdictclinicalwatch,stocksize0.

Start49.14fundcash/850.99equity,noopen/pending/closingpositions perownquery. Goalrepeatablepre-eventprofit; bindingconstraint independentexecutableedge. 1. Backtests38/1677failnetcostanduncertaintygates; CHWYrawquartercapital-.174722,LOVE stressnegative.2. CHWYcompletedrelease/openinggap-6.1023%isnewprospectiveevidence,notvalidatedposteventdrift.3. LOVEpaperentry15.87only,required1ADR/1.5ADRexit teststillfailed; cannotlateenterafterseeingreaction.4. Operationalreviewcomplete:135resolved,140CHWY16:30gapfollowup;136ASO/KFYand137LOVEtomorrowpreserved;5activecollectorscompleteincluding138END11. Conclusionnoorders/proposals,allocation0. Validity follows mandate'sedgegate; soundnesslimitedbysmallselectedsamples,delay/feedcoverage,unknownCHWYoriginalguide/callbridge. Favorablecashinvestmentreturnsandfuturereboundarestrongcounterexamplesbutdonotestablishpayoff. Evidencewouldmoveallocation: prospectivelyspecifiedcostedindependentpre-eventrulewithactual15minexitbehavior,crediblepositiveexpectancy andfreshquotes,thenquarterKellyand49.14fund/212.7475position/8.5099riskcaps. No need to spendremainingwallclockrerunningrejections. Sources https://www.sec.gov/Archives/edgar/data/1766502/000162828026061011/chwyq22026exhibit991.htm ; https://runway.adityaperswal.workers.dev/data/stock-bars ; runway:query_trades?fund=catalyst . No proposedtradecosts ormargin.

Premise1 SEC Q2OCF+3.5m whilecapex+19.9m; premise2 sales+5.7%excludingacquisitions; premise3 negativeopeningreactiondoesnotidentifycause. Firstorder: retainedFCFfalls16.4m as company invests in fulfillment/pharmacy/clinics/technology categories namedbyissuer. Secondorder,inference: equipmentproviders/builders/employees/acquiredowners canreceivecashbeforeincrementalowners'cashreturns; no namedbeneficiarytradewithoutcontractevidence. Thirdorder,conditional: ifinvestmentearnsadequateincrementalreturns,futureOCFcanexceedspending andsupportvalue; ifutilizationweakorcostsrecur,financing/opportunitycostsabsorbbenefits. StrongestcounterargumentlowercurrentFCFisdeliberateproductiveinvestment,notweakbusiness. Soundnesslimitedbynoasset-specificROICorfullacquisitionbridge; no priceforecast,FUNDproposalorpostearningsentry. Source https://www.sec.gov/Archives/edgar/data/1766502/000162828026061011/chwyq22026exhibit991.htm .

Reused,notrerun,recorded1720/1682MonteCarlo with1685Kellyunitcorrection. NumPyseed2026090908,50000bootstrap paths of10selectedtimeonlyeventreturns.25%capital hypotheticalmeanterminal51.17792 from49.14,5/50/95quantiles47.38995/50.79397/56.33595,lossprob25.418%. Thoseare10events,not10sessions orremainingmonth opportunities; sampleN10concentratedandrequiredcoststressedexitsnegative. NewSep9LOVEpaperoutcomeunfinished so cannotupdateempiricaldistribution. Favorableconditionalmean isstrongestcounterargumenttocash, butsimulationaddsnopopulationdata orvenueexitvalidation; adoptedallocation0,terminalcash49.14beforeexternalcosts. No liveprofitoddsclaimed. Sources https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; prioranalyses1682/1685/1720.

1. Read original backtests38,1677/78,1688 andqueriedownledger. CHWY chronologicalholdoutN6 p=.5 W=.04523391 L=.04828695,return-1.719988%,DD14.258614%; PythonquarterKellycapital(p/L-(1-p)/W)/4=-.1747224,clipped0. Prospective pre-event N1 -2.687668%remainsseparate. 2. LOVE1677N10 basep30%,W7.292817%,L2.929065%,return-.368512%,DD12.286896%; stressp20%,W10.702374%,L2.753813%,return-2.341352%,mean-.062576%,CI[-3.319283,4.058455]%. Selectedtimeonlygaincannotvalidate requiredexits; all CIs cross0.3. Own0/3wins,meanloss16.380601%,avgwinnerundefined,2operatorliquidations censorhorizon. Strongestcounterexample smallsamplecannotproveallfutureedgesnegative; conclusioniszerojustifiedallocationtoday,notuniversalinefficacy. No rerun of identical rejected backtests or parameter selection fromtoday'sgap. ExistingCLI58/1688diagnosticlimits retained. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; runway:query_trades?fund=catalyst ; originaldates inanalysis38observations84–101.